WALCHANNAGNSEWalchandnagar Industries Limited· Industrial ManufacturingHighNeutral
Announced Thu, 4 Dec, 2025 · 13:41 IST

Walchandnagar Q2 FY26 loss widens; revenue declines 24% YoY

Revenue DeclinePat NegativeResults View source PDFExplain this filing

WALCHANNAG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹167.00
prior close
₹166.90
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-1.1% vs market
Industrial Products peers, median of 113sector-0.7%-1.0% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.0 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.3
15m
-0.4
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.7-0.5-1.1-0.7-1.0
Next day
-4.9-1.7-3.3-1.1-3.9
2d
-9.0-4.0-5.0-3.1-5.9
3d
-4.3-2.1-2.2-1.9-2.4
4d
-8.9-2.7-6.2-2.5-6.4
5d
-7.5-2.3-5.3-2.1-5.4
1w
+3.6-1.5+5.1-0.8+4.4
15d
+13.7-1.8+15.5-1.7+15.4
1m
+12.0+0.1+11.8-1.7+13.7
2m
+9.9-3.3+13.2-7.6+17.4
3m
-3.6-11.2+7.6-15.7+12.1
UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 113Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY26 revenue fell to Rs 5,178 lakhs from Rs 6,786 a year ago, a 24% drop. Half year revenue dropped to Rs 10,122 lakhs from Rs 14,702. Loss before tax widened to Rs 2,229 lakhs in H1 from Rs 1,276. EPS was negative Rs 3.29 for H1. FY25 had a full year loss of Rs 8,603 lakhs. Operating cash flow stayed positive at Rs 1,215 lakhs. Auditor issued a clean limited review.

Likely market impact

Continued losses with declining revenues signal ongoing stress; no fresh capital or recovery plan announced in this filing.